Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT327 for Pruritus in Atopic Dermatitis
NCT01808157Phase 2Completed
- Sponsor
- Creabilis SA
- Start
- Jul 2013
- Primary completion
- Apr 2014
- Countries
- 1
01
Overview
A Phase 2 trial of pegcantratinib in atopic dermatitis (AD), sponsored by Creabilis SA. Started Jul 2013; status: completed.
02
Drugs
pegcantratinib
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01808157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01808157.